We will cover an overview of Claude API's capabilities, content marketing automation strategies, implementation case studies, technical aspects of integration, and ethical considerations.

Some professors have not changed their syllabus in recent years, while others have included additional non-reading materials.

Anthropic is accusing three Chinese artificial intelligence companies of "industrial-scale campaigns" to "illicitly extract" its technology using distillation attacks. Anthropic says these companies ...

Melissa Hughes teaches reading and English at Beechwood Elementary. With 22 years of education experience under her belt, Hughes is a nominee for Educator of the Year. In her application for the award ...

The Trump Administration’s extraordinary and politically motivated demand for information on nearly all federal funding going to 14 states and Washington, D.C. — all of which voted against the ...

We have all seen the headlines and read the stories regarding the issue of immigration enforcement and the tactics used by ICE. They have caused a great deal of concern for many of us. We have ...

Writing a blog is easy. But writing one that people actually read, comment on, and share with others is a real challenge. Many blogs look appealing at first sight. They have strong keywords and SEO ...

As animals go about their lives — eating, fighting, having babies — they don’t always follow the script laid out for them by Charles Darwin’s theory of evolution. Not every behavior furthers the cause ...

According to @pictoryai, Pictory AI enables businesses to automatically transform written blog articles into engaging product videos with branded visuals, captions, and AI-driven voiceovers in just ...

Last year I was in a discussion on Facebook about some of the techniques I've been using to help my travel blogs recover quickly from Google's HCU and other associated core updates. I shared a trick I ...

Ocugen has reported preliminary phase 2 data on its eye disease gene therapy, providing more evidence that the candidate may outperform existing treatments from Apellis Pharmaceuticals and Astellas ...